[1]
Hornyák, L., Nagy, Z., Vathy Fogarassyné, Ágnes, Endrei, D., Csákvári, T., Répásy, B., Kresz, S. and Boncz, I. 2021. The long-term effects of the biolicit procedure for original and biosimilar GCSF and EPO products in Hungary. Acta Pharmaceutica Hungarica. 91, 1 (Jun. 2021), 21-28. DOI:https://doi.org/10.33892/aph.2021.91.21-28.